News
Yale’s picks to beat cancer: a pair of aces
It has been an eventful December for the advancement of basic and translational cancer research at Yale. On the 13th, Yale University announced that Joseph Schlessinger, Ph.D., a world-renowned scientist with an unparalleled track record of identifying molecular targets for novel anticancer drugs, was named the first director of the University’s new Cancer Biology Institute (CBI), one of five major interdisciplinary research initiatives located on Yale’s West Campus. Just a week before, Thomas